The landscape of therapeutics for Niemann-Pick Disease Type C (NPC) is a rapidly changing one, with notable strides being made in research. Several promising therapeutic methods are currently experiencing investigational studies, offering optimism for patients living with this uncommon and progressive nervous system disorder. A mixture of medicati